AR050247A1 - Proceso para preparar la forma i de olanzapina - Google Patents

Proceso para preparar la forma i de olanzapina

Info

Publication number
AR050247A1
AR050247A1 ARP050101836A ARP050101836A AR050247A1 AR 050247 A1 AR050247 A1 AR 050247A1 AR P050101836 A ARP050101836 A AR P050101836A AR P050101836 A ARP050101836 A AR P050101836A AR 050247 A1 AR050247 A1 AR 050247A1
Authority
AR
Argentina
Prior art keywords
methylene chloride
olanzapine
solvate
layer
isolation
Prior art date
Application number
ARP050101836A
Other languages
English (en)
Spanish (es)
Inventor
Chava Satyanarayana
Gorantla Seeta Ramanjaneyulu
Abbeneni Jyothi Basu
Original Assignee
Matrix Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Lab Ltd filed Critical Matrix Lab Ltd
Publication of AR050247A1 publication Critical patent/AR050247A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ARP050101836A 2004-05-06 2005-05-06 Proceso para preparar la forma i de olanzapina AR050247A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN416CH2004 2004-05-06

Publications (1)

Publication Number Publication Date
AR050247A1 true AR050247A1 (es) 2006-10-11

Family

ID=35320627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101836A AR050247A1 (es) 2004-05-06 2005-05-06 Proceso para preparar la forma i de olanzapina

Country Status (2)

Country Link
AR (1) AR050247A1 (fr)
WO (1) WO2005107375A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1575962A1 (fr) 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Nouvelles formes cristallines d'olanzapine, procedes pour les preparer et procede pour preparer des formes cristallines d'olanzapine connues
WO2007138376A1 (fr) 2006-06-01 2007-12-06 Aurobindo Pharma Limited Procédé amélioré de préparation de la forme i d'olanzapine
PL381564A1 (pl) * 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
WO2008151430A1 (fr) * 2007-06-14 2008-12-18 Apotex Pharmachem Inc. Nouveaux procédés d'obtention de la forme-i de l'olanzapine
CN115340500A (zh) * 2021-05-14 2022-11-15 广东东阳光药业有限公司 一种含硫化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty

Also Published As

Publication number Publication date
WO2005107375A3 (fr) 2006-04-06
WO2005107375A2 (fr) 2005-11-17

Similar Documents

Publication Publication Date Title
AR050247A1 (es) Proceso para preparar la forma i de olanzapina
AR123811A2 (es) Composiciones de células madre mesenquimáticas purificadas y métodos relacionados
ES2400322T3 (es) Derivados de SF5 como inhibidores de PAR-1, su preparación y utilización como medicamento
AR068527A2 (es) Un procedimiento para preparar monohidrato de bromuro de tiotropio cristalino
NZ600199A (en) Method for producing methyl-{ 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate and its purification for use thereof as pharmaceutical substance
EA200801833A1 (ru) Способы получения кристаллических форм дулоксетина гидрохлорида
BR122017005939A2 (pt) processo para a fabricação de derivados de sulfamida pirimidina
DK146205B (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
EA200601742A1 (ru) Усовершенствованный способ производства хлорированной сахарозы
HK1087109A1 (en) Process for isolation and purification of paclitaxel from natural sources
WO2007052283A1 (fr) Procede ameliore de preparation de tadalafil et de son intermediaire
NO20053368L (no) Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
WO2005068464A2 (fr) Procede de preparation de tadalafil et ses intermediaires
ES2311282T3 (es) Procedimiento para purificar acido tioctico en agua.
ES2660393T3 (es) Método para purificar levo-oxiracetam
ATE403658T1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
IL195622A0 (en) Process for the purification of montelukast
RU2013134704A (ru) Способ производства проантоцианидиновой полимерной композиции
RU2007144707A (ru) Способ очистки бетанина
RU2015114079A (ru) Способ очистки 1,4-диаминобутана, очищенный указанным способом 1,4-диаминобутан и полученный из него полиамид
ES2318520T3 (es) Proceso mejorado para la fabricacion de mitazapina.
CA2968431C (fr) Procede de production de praziquantel
EA201290481A1 (ru) Способ получения гидрохлорида прасугреля в полиморфной форме в
CN101906103A (zh) 四氢-β-咔啉化合物合成方法的改进
AR071546A1 (es) Proceso para recuperar florfenicol y analogos de florfenicol. metodo.

Legal Events

Date Code Title Description
FB Suspension of granting procedure